(Q34065513)

30 July 2017

Treatment of progressive pulmonary sarcoidosis with cyclosporin A. A randomized controlled trial (English)

1 reference

30 July 2017

pulmonary sarcoidosis

1 reference

Wyser CP

1

1 reference

30 July 2017

van Schalkwyk EM

2

1 reference

30 July 2017

Alheit B

3

1 reference

30 July 2017

Bardin PG

4

1 reference

30 July 2017

Joubert JR

5

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 November 1997

1 reference

American Journal of Respiratory and Critical Care Medicine

30 July 2017

1 reference

30 July 2017

156

1 reference

30 July 2017

5

1 reference

30 July 2017

1371-1376

1 reference

Outcome of the treatment for sarcoidosis

30 July 2017

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.5.9506031

Low-dose allopurinol plus azathioprine/cyclosporin/prednisolone, a novel immunosuppressive regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.5.9506031

Successful treatment of life-threatening steroid-resistant pulmonary sarcoidosis with cyclosporin in a patient with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.5.9506031

Cyclosporin as a treatment for interstitial lung disease of unknown aetiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.5.9506031

Growth and decay of pulmonary function in healthy blacks and whites

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.5.9506031

The roentgenographic staging of sarcoidosis. Historic and contemporary perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.5.9506031

Clinical role of bronchoalveolar lavage in adults with pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.5.9506031

The effects of chloroquine on serum 1,25-dihydroxyvitamin D and calcium metabolism in sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.5.9506031

The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.5.9506031

Pulmonary sarcoidosis and corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.5.9506031

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.5.9506031

10.1164/AJRCCM.156.5.9506031

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference